IRCT20170614034526N5已完成未知
Prospective Efficacy & Safety study of Monotherapy or Combination therapy with Dapagliflozin in reduction of HbA1C and Body Weight in newly diagnosed or treatment experienced Type II Diabetes Mellitus Patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Male & Female (Non-pregnant) Patients = 18 years of age with type II Diabetes Mellitus.
- •Type II diabetes mellitus patients having controlled diabetes HbA1C 7-10 % or uncontrolled diabetes (HbA1C 10-12%).
- •Patients having BMI of > 25 kg/m2.
- •Not Hypersensitive to Dapagliflozin or any of ingredients.
排除标准
- •Male & Female Type I Diabetes patients.
- •Patients having complaints of urinary tract infections, genital infections
- •Patients with e GFR < 60 mL/min/1.73 m².
- •Pregnant Females.
- •Patients with end stage renal disease, or going through dialysis.
- •Suspected Ketoacidosis patients.
研究者
相似试验
已完成
不适用
A retrospective observational study of monotherapy outcomes on the efficacy of third-line or later treatment for patients with HER2 positive unresectable recurrent or metastatic gastric cancer previously treated with trastuzumabHER2 positive unresectable recurrent or metastatic gastric cancerJPRN-UMIN000040853Graduate school of Medicine OSAKA UniversityDepartment of Gastroenterological Surgery100
进行中（未招募）
1 期
Study of the efficacy and safety of Lcr Regenerans®_GynoCans.EUCTR2013-002480-26-PLBIOSE234
进行中（未招募）
1 期
Study of the efficacy and safety of treatment administered intravaginallyin the treatment of bacterial vaginosis.MedDRA version: 19.0Level: LLTClassification code 10046960Term: Vaginosis bacterialSystem Organ Class: 100000004862Bacterial vaginosisEUCTR2015-004563-37-PLaboratoires IPRAD PHARMA530
招募中
2 期
Efficacy and safety study of a therapeutic regimen using Tamibarotene (Am80) and arsenic trioxide (ATO) in combination with Gemtuzumab Ozogamicin (GO) as a post-remission therapy for relapsed acute promyelocytic leukemia (APL)Relapsed acute promyelocytic leukemiaRelapsed acure promyelocytic leukemia, Tamibarotene, Arsenic trioxide, Gemtuzumab ozogamicinJPRN-jRCTs041190101Kiguchi Toru39
已完成
不适用
Study on the safety and efficacy of the treatment of polidocanol injection for vascular lesions in the small bowel.Vascular lesions in the small bowelJPRN-UMIN000009712niversity of Tokyo20